APGE Stock Analysis: Buy, Sell, or Hold?

APGE - Apogee Therapeutics, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$132.55
42.17 (46.66%) β–²
5d: +50.06%
30d: +62.86%
90d: +100.71%
WAIT
LOW Confidence
Protect Your APGE Gains
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 10, 2026

Get Alerted When APGE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: APGE is 38.7% above its trading range ($95.54). While momentum could continue, risk/reward favors waiting for a pullback.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: APGE is currently trading at $132.55, which is considered extended relative to its 30-day fair value range of $75.15 to $95.54.

Technical Outlook: Technically, APGE is in a uptrend. The price is approaching resistance at $133.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 46.7% recently.

Market Sentiment: APGE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $75.15 - $95.54
Company Quality Score 66/100 (BUY)
Volume Confirmation MODERATE
Confidence Score 44.7%

Protect Your Profits

APGE is technically overbought (RSI 82). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

All Signals

  • BEARISH: Price significantly overextended (+38.7% above its trading range)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: Strong upward momentum (+46.7%)
  • BEARISH: Trading above Wall St target ($119.50)

Trading Range Analysis

30-Day Trading Range $75.15 - $95.54
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $81.04
Resistance Level $133.00
Current Trend Uptrend
Technical data as of Jun 22, 2026

Fundamental Context

Forward P/E (Next Year Est.) -25.52
Wall Street Target $119.50 (-9.8%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 23, 2026 9:40 AM ET
Data refreshes hourly during market hours. Next update: 10:40 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Thomas Henderson SELL 20000 shares 2026-04-08
Carl Dambkowski SELL 5500 shares 2026-04-01
Michael Thomas Henderson SELL 20000 shares 2026-03-11

Unlock Insider Activity

See real-time buying/selling by company executives for APGE.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$34 67 BUY
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 66 BUY
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 67 BUY
MNMD
Mind MedicineΒ Inc
STRONG BUY
11 analysts
$29 62 BUY
IRON
Disc Medicine Inc.
STRONG BUY
11 analysts
$102 61 BUY

Advanced APGE Option Strategies

Professional options setups generated by AI based on today's APGE price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for APGE

APGE Technical Chart APGE Price Prediction APGE Earnings Date APGE Investment Advisor APGE Fair Price Analyzer APGE Options Advisor APGE Options Chain APGE Options Analysis APGE Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals